About
Our Name
Mission
Values
Leadership
Board of Directors
Investors
Newsroom
Press Releases
In the News
Events
Contact
About
Our Name
Mission
Values
Leadership
Board of Directors
Investors
Newsroom
Press Releases
In the News
Events
Contact
IN THE NEWS
Aristea contemplates Phase III design for rare skin disease drug
July 14, 2022
Original Article Link
2023 © Copyright. Aristea Therapeutics. All Rights Reserved.
